| Ytd | 78.53% | |
| 1y | 241.11% |
| Open | 44.74 | Prev Close | 44.58 | Low | 43.73 | High | 45.75 | Mkt Cap | 4.77B |
| Vol | 0.00 | Avg Vol | 1.42M | EPS | -1.85 | P/E | -23.95 | Forward P/E | -28.57 |
| Beta | 0.33 | Short Ratio | 6.06 | Inst. Own | 112.49% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-06 | 50-d Avg | 39.50 | 200-d Avg | 30.56 | 1yr Est | 50.85 |
EWTX News
– Announced positive top-line data from 12-week Phase 2 CIRRUS-HCM trial with EDG-7500 in obstructi
Evercore ISI Group analyst Cory Kasimov maintains Edgewise Therapeutics (NASDAQ:EWTX) with a Outp
— Edgewise receives $1.55 billion in upfront cash and is eligible to receive up to $1.1 billion in r
BOULDER, Colo., July 1, 2026 /PRNewswire/ -- Edgewise Therapeutics, Inc. ("Edgewise" or the "Company
Top analysts changed outlook on top names: Intuit downgraded, Alkermes price target raised, Carmax t
Top Wall Street analysts changed outlook on top names. Baird raised prices for Ryder System and J
Edgewise Therapeutics, Inc. (EWTX) Discusses Top Line Data From EDG-7500 Phase II CIRRUS-HCM Trial i
Edgewise Therapeutics Inc. (NASDAQ:EWTX) on Tuesday released topline results from the 12-week Part D
Edgewise Therapeutics shares fell nearly 10% on Tuesday after the efficacy of its experimental heart
– No relationship observed between EDG-7500 exposure and LVEF; no LVEF reductions below 50% – – Cons
Edgewise Therapeutics remains a "Buy," driven by pipeline focus and a transformative $2.65B sale of
BOULDER, Colo., June 3, 2026 /PRNewswire/ -- Edgewise Therapeutics, Inc. ("Edgewise" or the "Company
EWTX surges 18% to a record high after striking a $2.65 billion neuromuscular business divestiture d
Several stocks, including Optimum Communications Services, surged while Dow fell. Technology, energy
Biotech firm Edgewise Therapeutics said on Monday it would sell its experimental muscular dystrophy
— Edgewise to Receive $1.55 Billion in Upfront Cash Consideration and is Eligible to Receive up to $
BOULDER, Colo., May 12, 2026 /PRNewswire/ -- Edgewise Therapeutics, Inc. (Nasdaq: EWTX), a leading m
– Announced positive long-term sevasemten data demonstrating sustained functional stabilization in
Dow Jones up 200 points, Rockwell Automation shares rise 10.8% on strong earnings and raised guidanc
BOULDER, Colo., May 4, 2026 /PRNewswire/ -- Edgewise Therapeutics, Inc. ("Edgewise" or the "Company"
ABVC BioPharma (NASDAQ: ABVC - Get Free Report) and Edgewise Therapeutics (NASDAQ: EWTX - Get Free R
Edgewise Therapeutics, Inc. (NASDAQ: EWTX - Get Free Report) shares hit a new 52-week high on Tuesda
Shares of Edgewise Therapeutics, Inc. (NASDAQ: EWTX - Get Free Report) have been given an average ra
SG Americas Securities LLC raised its position in shares of Edgewise Therapeutics, Inc. (NASDAQ: EWT
Edgewise Therapeutics, Inc. (NASDAQ: EWTX - Get Free Report) CMO Joanne Donovan sold 28,662 shares o
Shares of TransCode Therapeutics, Inc. (NASDAQ: RNAZ) fell sharply during Friday’s session. TransCo
On Wednesday, 215 companies set new 52-week lows.
On Tuesday, 540 companies set new 52-week lows.
On Friday, 1043 companies hit new 52-week lows.
During Thursday, 849 stocks hit new 52-week lows.
On Friday, 166 companies set new 52-week lows.
On Thursday, 112 stocks made new 52-week lows.
During Tuesday's session, 454 stocks hit new 52-week lows.
During Monday's session, 291 companies made new 52-week lows. Also check out this: Insid